Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 19 Feb 2026 for Precision Biosciences INC. Read the official filing
Filing timeline
BuySaleMichael Amoroso
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Amoroso: trading record in brief
Michael Amoroso, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Precision Biosciences Inc and Abeona Therapeutics Inc. Over a trading history stretching from 30 September 2021 to 17 February 2026, the count stands at 29 filings.
The open-market record consists of 11 sales worth €176k, with no purchase. Besides market trades, the filings include 7 share grants and 11 option exercises.
Most recently, on 19 February 2026, the filings show an option exercise in Precision Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Amoroso
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
67,797 shares0Common StockSEC:0001628280-26-009804:0
37,313 shares0Common StockSEC:0001493152-26-003806:0
8,888 sharesCommon StockSEC:0001628280-26-003149:0
3,409 shares@ US$6.499.6% of flowCommon StockSEC:0001628280-25-048855:1
9,444 shares0Common StockSEC:0001628280-25-048855:0
964 shares@ US$5.562.5% of flowCommon StockSEC:0000950170-25-044599:1
3,417 sharesCommon StockSEC:0000950170-25-044599:0
36,101 shares0Common StockSEC:0001493152-25-004750:0
115,388 sharesCommon StockSEC:0000950170-25-008013:0
3,012 shares@ US$8.1911.3% of flowCommon StockSEC:0000950170-24-121726:1
9,443 sharesCommon StockSEC:0000950170-24-121726:0
11,797 shares0Common StockSEC:0001493152-24-034052:0
23,611 shares0Common StockSEC:0001493152-24-026645:0
8,334 shares@ US$12.0046.5% of flowCommon StockSEC:0000950170-24-056141:0
3,417 sharesCommon StockSEC:0000950170-24-053112:0
266,720 sharesCommon StockSEC:0001209191-24-002119:0
137,390 shares@ US$0.3622.7% of flowCommon StockSEC:0001209191-24-002119:1
283,390 sharesCommon StockSEC:0001209191-23-054549:0
5,508 shares@ US$3.91115.7% of flowCommon StockSEC:0001493152-23-034855:0
327 shares@ US$3.900.3% of flowCommon StockSEC:0001493152-23-033446:0
338 shares@ US$4.450.4% of flowCommon StockSEC:0001493152-23-021996:0
58,689 shares@ US$4.6269.2% of flowCommon StockSEC:0001493152-23-021653:0
102,535 sharesCommon StockSEC:0001209191-23-020716:0
268 shares@ US$2.330.2% of flowCommon StockSEC:0001493152-23-008429:0
1,002 shares@ US$2.380.6% of flowCommon StockSEC:0001493152-23-006716:0
25 of 29 declarations
